Head Lice
Authors:
- Terri L MeinkingTMTerri L Meinking
- Craig G BurkhartCBCraig G Burkhart
- Craig N BurkhartCBCraig N Burkhart
- 24 October 2002
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 347 (17) , 1381-1382
Abstract
In his article on head lice (May 23 issue),1 Roberts discusses several possible treatments. On the basis of in vitro studies of both sensitive and resistant head lice as well as clinical experience in the United States, topical malathion appears to be the most effective treatment. However, studies of shorter application times (10 to 30 minutes) and in children less than six years of age should be conducted.2-4 The formulation of malathion that is available in the United States is very effective, but this product is not available in other countries. Lindane, which is now banned in California, should never be used because of its toxic effects, lack of efficacy, and potential for contaminating the environment.2-4 There is strong need for the Food and Drug Administration to approve alternative agents, including topical and oral ivermectin and other noninsecticidal pediculicides.2Keywords
This publication has 2 references indexed in Scilit:
- Head LiceNew England Journal of Medicine, 2002
- Comparative In Vitro Pediculicidal Efficacy of Treatments in a Resistant Head Lice Population in the United StatesArchives of Dermatology, 2002